Product
EQ001
Aliases
EQ001 Placebo
2 clinical trials
6 indications
Indication
Acute Graft Versus Host DiseaseIndication
acute graft-versus-host diseaseIndication
Graft-versus-host diseaseIndication
AcuteIndication
Graft-Versus-Host DiseaseIndication
Acute GVHDClinical trial
A Phase 1b/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of EQ001 in Subjects With Newly Diagnosed Acute Graft Versus Host DiseaseStatus: Completed, Estimated PCD: 2022-11-21
Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination With Corticosteroids for the Initial Treatment of Acute Graft Versus Host DiseaseStatus: Recruiting, Estimated PCD: 2024-07-01